RxDoctor Payments Data

Bryon Butts, DPM

Podiatrist · New York, NYNPI 1720192875

Payments from drug & device makers

$1,485in general payments, 2019–2025

Across 65 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$742
  • Nevro Corp.$196
  • Crossroads Extremity Systems, LLC$150
  • Osiris Therapeutics Inc.$120
  • Sebela Pharmaceuticals Inc.$79
  • Novum Pharma, LLC$62
  • plus $136 from 4 others

What the payments were for

  • Food & beverage$1,485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)48$742
Nevro Corp.1$196
Crossroads Extremity Systems, LLC1$150
Osiris Therapeutics Inc.1$120
Sebela Pharmaceuticals Inc.3$79
Novum Pharma, LLC4$62
Pfizer3$49
Zyla Life Sciences, Inc.2$43
Treace Medical Concepts, Inc.1$30
Dynasplint Systems Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,485 in reported general payments places this provider in the 65th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$17,667
Medicare patients
38
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →